In all seriousness, this trial could well spell the beginning of the end of SOC Chemo if PD1-Vaxx works as anticipated. Imagine at end of the first cohort and the outcome is this. All patients on PD1 alone and those on PD1 with SOC are doing fine. Except those with SOC loses all hairs along with all the other side effects that the toxic SOC brings. Just that alone will do PD1-Vaxx real good.
Ann: Imugene First Patient Dosed in PD1-VAXX Clinical Trial, page-69
-
- There are more pages in this discussion • 56 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.9¢ |
Change
0.005(9.26%) |
Mkt cap ! $433.6M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.9¢ | 5.4¢ | $1.489M | 25.99M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 35252 | 5.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.0¢ | 1753430 | 24 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |